HILLEMAN JERYL L 4

What Happened

• Jeryl L. Hilleman, a director of Omada Health, received a grant of 10,882 restricted stock units (RSUs) on June 16, 2026. The RSUs were granted at $0.00 per unit (total reported value $0) and represent the right to receive one share of common stock per RSU upon vesting. This is an award/grant (transaction code A), not an open-market buy or sale.

Key Details

• Transaction date: 2026-06-16; filing date: 2026-06-18 (filed within the normal Form 4 window).
• Grant: 10,882 RSUs at $0.00 (total reported value $0); transaction code A = Award/Grant.
• Shares owned after transaction: not disclosed in the filing.
• Footnote: The RSUs vest 100% on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of stockholders, subject to continued service through the vesting date.
• No indication of tax withholding, 10b5-1 plan, or sale of shares in this filing.

Context

• RSUs are a form of compensation that convert to shares upon vesting; they do not require an upfront cash purchase. Such director grants are common and reflect compensation/retention rather than an immediate market bet. Because these shares are subject to a time- and service-based vesting condition, they do not represent immediately tradable stock.